Smart Money Decisions. Start Here.
Apellis price target lowered to $18 from $20 at Wedbush
Wedbush lowered the firm’s price target on Apellis (APLS) to $18 from $20…
Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley
B. Riley raised the firm’s price target on Vanda Pharmaceuticals (VNDA) to $17…
Top Catagories. Discover all of our topics.
Auto
0articles
Banking
0articles
Blog
0articles
Budgeting
0articles
Credit Cards
0articles
Credit Score
0articles
Dept Payoff
0articles
Emergency Funds
0articles
ETFs
0articles
Finance News
3073articles
More popular. Click on the post and enjoy.
Watch, Read, Listen
SUPPER CHANGE YOUR PLANNING POWERS
Join our newsletter.
Experience the fusion of imagination and expertise with Études—the catalyst for architectural.
01
Create a free account
02
Write your story
Watch, Read, Listen
GET STARTED
Join 900+ subscribers
Get the cheat codes for selling and
unlock your team’s revenue potential.
